Promising role for whole genome sequencing in guiding blood cancer treatment
Helpful behavior during pandemic tied to recognizing common humanity
10 March 2021Clinical trial shows alcohol use disorder recovery can start without sobriety
10 March 2021Promising role for whole genome sequencing in guiding blood cancer treatment
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes. Some of these tests rely on technology that was invented more than 60 years ago and has been used clinically for the past three decades.
